These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3033815)

  • 1. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran.
    Mortensen PB; Andersen JR; Arffmann S; Krag E
    Scand J Gastroenterol; 1987 Mar; 22(2):185-92. PubMed ID: 3033815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?
    Cann PA; Read NW; Holdsworth CD
    Gut; 1984 Feb; 25(2):168-73. PubMed ID: 6319244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing butyrate concentration in the distal colon by accelerating intestinal transit.
    Lewis SJ; Heaton KW
    Gut; 1997 Aug; 41(2):245-51. PubMed ID: 9301506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study.
    Arffmann S; Andersen JR; Hegnhøj J; Schaffalitzky de Muckadell OB; Mogensen NB; Krag E
    Scand J Gastroenterol; 1985 Apr; 20(3):295-8. PubMed ID: 2988107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of plantago seed husks in comparison with wheat brain on stool frequency and manifestations of irritable colon syndrome with constipation].
    Hotz J; Plein K
    Med Klin (Munich); 1994 Dec; 89(12):645-51. PubMed ID: 7869999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.
    Lucey MR; Clark ML; Lowndes J; Dawson AM
    Gut; 1987 Feb; 28(2):221-5. PubMed ID: 3030904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of ispaghula husk and lactulose on the in vivo and the in vitro production capacity of short-chain fatty acids in humans.
    Rasmussen HS; Holtug K; Andersen JR; Krag E; Mortensen PB
    Scand J Gastroenterol; 1987 May; 22(4):406-10. PubMed ID: 3037683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
    Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N
    World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations.
    Zoran DL; Turner ND; Taddeo SS; Chapkin RS; Lupton JR
    J Nutr; 1997 Nov; 127(11):2217-25. PubMed ID: 9349850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.
    Kruis W; Weinzierl M; Schüssler P; Holl J
    Digestion; 1986; 34(3):196-201. PubMed ID: 3019810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The colon in carbohydrate malabsorption: short-chain fatty acids, pH, and osmotic diarrhoea.
    Holtug K; Clausen MR; Hove H; Christiansen J; Mortensen PB
    Scand J Gastroenterol; 1992 Jul; 27(7):545-52. PubMed ID: 1641581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).
    Parisi GC; Zilli M; Miani MP; Carrara M; Bottona E; Verdianelli G; Battaglia G; Desideri S; Faedo A; Marzolino C; Tonon A; Ermani M; Leandro G
    Dig Dis Sci; 2002 Aug; 47(8):1697-704. PubMed ID: 12184518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic dysfunction in acute diarrhoea: the role of luminal short chain fatty acids.
    Ramakrishna BS; Mathan VI
    Gut; 1993 Sep; 34(9):1215-8. PubMed ID: 8406157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.
    Müller-Lissner SA
    Br Med J (Clin Res Ed); 1988 Feb; 296(6622):615-7. PubMed ID: 2832033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
    Farup PG; Rudi K; Hestad K
    BMC Gastroenterol; 2016 Apr; 16(1):51. PubMed ID: 27121286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of wheat bran particle size and tissue composition affects colonisation and metabolism by human faecal microbiota.
    De Paepe K; Verspreet J; Rezaei MN; Martinez SH; Meysman F; Van de Walle D; Dewettinck K; Courtin CM; Van de Wiele T
    Food Funct; 2019 Jan; 10(1):379-396. PubMed ID: 30604790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal changes in large-bowel metabolism: short-chain fatty acids and transit time in rats fed on wheat bran.
    Mathers JC; Tagny JM
    Br J Nutr; 1994 Feb; 71(2):209-22. PubMed ID: 8142333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans.
    McOrist AL; Abell GC; Cooke C; Nyland K
    Br J Nutr; 2008 Jul; 100(1):138-46. PubMed ID: 18205991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.